Jun 16, 2020
Intra-abdominal Pressure Measurement Devices Market Size Worth $197.5 Million by 2027: Grand View Research, Inc.
May 18, 2020
Sight Sciences Announces Positive Clinical Results from Randomized, Controlled Trial of TearCare for the Treatment of Dry Eye Disease
May 18, 2020
Oculis Reports Positive Top-line Data From SKYGGN (Phase 2) Trial With OCS-01 for Treating Inflammation and Pain Following Cataract Surgery
May 08, 2020
New Study Finds Oxaloacetate Significantly Lowers PMS Mood Symptoms
Apr 29, 2020
Windtree Announces First Patient Enrolled in AEROSURF® Bridging Study for the Treatment of Respiratory Distress Syndrome
Mar 24, 2020
The Sullivan Group and The VEDS Movement Collaborate to Increase VEDS Awareness & Diagnosis
Mar 17, 2020
Cellenkos Inc. Focuses on the Development of Cell-Therapy for Treatment of COVID-19 Mediated Acute Respiratory Distress Syndrome (CoV-ARDS)
Mar 09, 2020
The global premenstrual syndrome treatment market was valued at $1,129 million in 2018, and is projected to reach $1,516 million by 2026, registering a CAGR of 3.7% from 2019 to 2026
Feb 18, 2020
Moleculin Presents Clinical Trial Data Demonstrating a Median Reduction of 56% in Skin Cancer Lesions
Feb 10, 2020
Global DEE Market Insights, 2017-2028 - Eisai Pharmaceuticals (Fycompa; Perampanel), Zogenix (Fintepla; ZX008), Takeda/Ovid (Soticlestat; TAK-935/OV935), and Zynerba Pharma (Zygel; ZYN002)
Feb 05, 2020
PMS Relief Product Bests the Competition with Top Rating from TopConsumerReviews.com
Jan 27, 2020
Fragile X Syndrome (FXS): Current Treatment Practices, Emerging Drugs, Market Share of Individual Therapies, Current & Forecasted Market Size from 2017 to 2028 Segmented by 7 Major Markets
Jan 16, 2020
Get a Grip? It's All About Pain for Thumb Tendonitis Patients
Jan 10, 2020
IDEAYA Biosciences and Boston Children's Hospital Collaborate on Preclinical Evaluation of IDE196 for Sturge Weber Syndrome - a Rare Disease Associated with Genetic Mutation of GNAQ
Jan 08, 2020
Entrada Therapeutics Announces ENTR-501 for the Treatment of Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE)
Jan 07, 2020
VectivBio Launches with $35M Financing to Bring Best-in-Disease Medicines to Patients with Serious Rare Diseases
Dec 18, 2019
REGENXBIO Announces Interim Data from Phase I/II Trial of RGX-121 for the Treatment of Mucopolysaccharidosis Type II (MPS II)
Dec 11, 2019
Restless Leg Syndrome Product Moves to 1st Place in Ratings from TopConsumerReviews.com
Dec 07, 2019
Mallinckrodt Presents Data on a Novel Predictive Model to Identify Infants at Risk for Infantile Spasms (IS) at the 2019 Annual Meeting of the American Epilepsy Society (AES)
Dec 06, 2019
SK life science to Present Latest Cenobamate Data at the American Epilepsy Society 2019 Annual Meeting